Turning Point Therapeutics and EQRx Announce Clinical Collaboration
Turning Point Therapeutics and EQRx Announce Clinical Collaboration to Evaluate Elzovantinib in Combination with Aumolertinib…
Arboretum_JDOctober 14, 2021